amherst23

Dendreon 2007 Annual Report and How Provenge Will Propel Company

i have traded DNDN stock and own it now for the same reasons identified in the blog

in order to further understand prostate cancer i have done some research and set up a web site chronicling the relevant information about prostate cancer at this site:

prostatecancer.boomja..../

have a look




On Jan 27 02:49 PM Frankie62 wrote:

> sdbanks left out that the primary opponent of Provenge wrote letters
> urging FDA NOT to approve Provenge for prostate cancer, in spite
> of the panel vote. There have been lawsuits filed. The same opponent
> has sources of revenue from the current "accepted" treatment - radiation
> and chemotherapy (which have devastating side effects), major conflicts
> of interest. The victims in final stages of PC have been begging
> for access to Provenge - it not only extends life, but there are
> virtually no side effects. DNDN's Provenge and Neuvenge are immunotherapies
> which are customized for each patient, using their individual blood.

On the Mini-Madoffs: Ponzi Scheme Arrests Surge

The madoff fraud and the impact on the fund managment biz as well as ponzi schemes is all chronicled here:

madofffraud.boomja.com/